QUOIN PHARMACEUTICALS LT-ADR (QNRX) Stock Cash Flow
NASDAQ:QNRX - Nasdaq - US74907L3006 - ADR
| TTM (2024-6-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -8.28M | -8.69M | -9.38M | -21.46M | -5.26M | |||
| Depreciation Amortization | 103.71K | 103.71K | 100.00K | 100.00K | 210.00K | |||
| Change In Working Capital | -633.14K | 95.45K | 620.00K | 1.33M | -100.00K | |||
| Interest Paid | N/A | N/A | 0.00 | 390.00K | N/A | |||
| Other non cash items | 821.40K | 622.99K | 180.00K | 14.31M | 650.00K | |||
| OPERATING CASH FLOW | -7.99M | -7.86M | -8.48M | -5.72M | -4.50M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | N/A | N/A | -250.00K | -630.00K | -100.00K | |||
| Other Investing Activity | 1.34M | 2.19M | -9.90M | N/A | 10.00K | |||
| INVESTING CASH FLOW | 1.34M | 2.19M | -10.15M | -630.00K | -80.00K | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -720.00K | -600.00K | -910.00K | 3.31M | -130.00K | |||
| Stock Issued/Repurchased | 5.50M | 5.85M | N/A | N/A | 4.02M | |||
| Other Financing Activity | N/A | -32.58K | 14.92M | 10.19M | N/A | |||
| FINANCING CASH FLOW | 4.74M | 5.22M | 14.01M | 13.50M | 3.89M | |||
| Exchange Rate Effect | N/A | N/A | N/A | N/A | 370.00K | |||
| CHANGE IN CASH | -1.91M | -459.43K | -4.62M | 7.15M | -320.00K | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -7.99M | -7.86M | -8.48M | -5.72M | -4.50M | |||
| Capital Expenditure | N/A | N/A | -250.00K | -630.00K | -100.00K | |||
| FREE CASH FLOW | -7.99M | -7.86M | -8.73M | -6.35M | -4.60M | |||
All data in USD